Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05868577 · ClinicalTrials.gov registry record · Phase 1
Infracalcaneal Peppering Injection Technique for Chronic Plantar Fasciitis
A Phase 1 study, sponsored by Wake Forest University Health Sciences.
- Completed
- Registry status
- Phase 1
- Development phase
- 41
- Enrollment target
NCT05868577 is a Phase 1 study that has completed, run by Wake Forest University Health Sciences. The registered enrollment target is 41 participants.
The verdict
NCT05868577, a Phase 1 study, has completed, sponsored by Wake Forest University Health Sciences.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 41 participants
- Enrollment target
Study Summary
Although no single treatment has shown superiority, short-term pain relief may be offered via a targeted local corticosteroid injection (CSI), used often in combination with local anesthetic (LA), which may reduce plantar fasciitis symptoms for up to 1 month. Moreover, administering a CSI is relatively quick and easy for any Provider to perform, though it is not without potential deleterious side effects and risks, including fibroblast degradation, fat pad atrophy, skin depigmentation, and even plantar fascia rupture.
Interventions
- DRUG Corticosteroid injection (CSI) with local anesthetic (LA)
- DRUG Local anesthetic (LA) with Saline injection
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 41 participants |
| Start Date | 2023-10-18 |
| Est. Completion | 2024-09-18 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05868577
The ClinicalTrials.gov registry entry for NCT05868577 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 41 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Wake Forest University Health Sciences, which has 1,140 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Corticosteroid injection (CSI) with local anesthetic (LA) is the first listed.
NCT05868577 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05868577 about?
NCT05868577 is a clinical study titled "Infracalcaneal Peppering Injection Technique for Chronic Plantar Fasciitis". Although no single treatment has shown superiority, short-term pain relief may be offered via a targeted local corticosteroid injection (CSI), used often in combination with local anesthetic (LA), which may reduce plantar fasciitis symptoms for up to 1 month. Moreover, administering a CSI is relativ...
What is the current status of trial NCT05868577?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 41 participants. The study started on 2023-10-18. Estimated completion is 2024-09-18.
What interventions are being tested in trial NCT05868577?
The interventions under investigation include: Corticosteroid injection (CSI) with local anesthetic (LA) (DRUG), Local anesthetic (LA) with Saline injection (DRUG).
Who is sponsoring clinical trial NCT05868577?
This trial is sponsored by Wake Forest University Health Sciences, which has 1,140 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.